New
Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Advertisement
Advertisement
FMEDvsETF 2ETF Comparison
Choose a second ETF to run a side-by-side ETF comparison with FMED, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FMED performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 03/18/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FMED ETF 2 | -6.92%– | -10.09%– | -10.31%– | -0.32%– | n/a– | n/a– |
| Flows | FMED ETF 2 | -– | -– | -– | +$5M– | -– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FMED ETF 2 | +19.28%– | +19.99%– | n/a– | n/a– |
| Max drawdown | FMED ETF 2 | -14.72%– | -15.97%– | n/a– | n/a– |
| Max drawdown duration | FMED ETF 2 | 55d– | 108d– | n/a– | n/a– |
Trading data
FMED | ETF 2 | |
Last sale 3/18/2026 at 1:30 PM | $24.30 | – |
| Previous close 03/18/2026 | $24.77 | – |
| Consolidated volume 03/18/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 3/18/2026 at 1:30 PM
Live
Closed
FMED | ETF 2 | |
|---|---|---|
| Last price | $24.30 | – |
| 1D performance | -1.91% | – |
| AuM | $56.47 M | – |
| E/R | 0.5% | – |
Characteristics
FMED | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Fidelity | – |
| Benchmark | - | – |
| N° of holdings | 50 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 12, 2023 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
FMED
USA
89.2%
Other
10.8%
ETF 2
Sectors
FMED
Health Care
82.23%
Other
17.77%
ETF 2
Advertisement
Diversification
FMED
Total weight of top 15 holdings out of 15
47.79%
ETF 2
–
Top 15 holdings
Data as of January 31, 2026
FMED
BOSTON SCIENTIFIC
4.76%
DANAHER
4.37%
US04016X1019
4.08%
UCB
3.98%
COGENT BIOSCIENCES
3.65%
VEEVA SYSTEMS IN
3.45%
PENUMBRA
3.38%
ALNYLAM PHARMACEUTICALS
3.35%
INTUITIVE SURGICAL
2.81%
US9467841055
2.63%
INSULET
2.61%
LIFESTANCE HEALTH GROUP
2.33%
EDWARDS LIFESCIENCES
2.26%
MODERNA INC
2.10%
STEDIM
2.06%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
Advertisement
Webcast on Demand
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
